Shareholder Votes

FIRST ADVANTAGE CORP shareholders approved Advisory Vote on Compensation of Named Executive Officers at the 2026-06-05 meeting.

“Proposal No. 3-Advisory Vote on Compensation of Named Executive Officers. The stockholders approved, on an advisory (non-binding) basis, the compensation of our named executive officers. The voting results were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 157,302,586 2,478,182 32,472 2,448,868”

FIRST ADVANTAGE CORP shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-06-05 meeting.

“Proposal No. 2-Ratification of Independent Registered Public Accounting Firm. The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The voting results were as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 162,194,290 38,636 29,182 N/A”

FIRST ADVANTAGE CORP shareholders approved Election of Directors at the 2026-06-05 meeting.

“Proposal No. 1-Election of Directors. The stockholders elected the individuals listed below as Class II directors to serve on the Company’s Board of Directors for a three-year term expiring in 2029. The voting results were as follows: Name Votes For Votes Withheld Broker Non-Votes James L. Clark 135,542,912 24,270,328 2,448,868 Bridgett R. Price 149,762,902 10,050,338 2,448,868 Mark Gillett 126,937,736 32,875,504 2,448,868”

APPIAN CORP shareholders approved Approval of the amended and restated 2017 Equity Incentive Plan at the 2026-06-03 meeting.

“Proposal 5 - Approval of the Amended and Restated 2017 Equity Incentive Plan The Company's stockholders approved Proposal 5. The votes were cast as follows: Votes For Votes Against Abstained Broker Non-Votes 303,474,350 18,783,302 33,065 6,336,379”

APPIAN CORP shareholders approved Advisory vote on the frequency of future advisory votes on named executive officer compensation at the 2026-06-03 meeting.

“Proposal 4 - Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation The Company's stockholders indicated, on a non-binding advisory basis, the preferred frequency for the solicitation of future advisory stockholder approval of compensation paid to the Company's named executive officers be held every year. The votes were cast as follows: 1 year 2 years 3 years Abstained 322,210,378 16,527 17,032 46,780”

APPIAN CORP shareholders approved Advisory vote on executive compensation at the 2026-06-03 meeting.

“Proposal 3 – Advisory Vote on Executive Compensation The Company’s stockholders approved, on a non-binding advisory basis, Proposal 3. The votes were cast as follows: Votes For Votes Against Abstained Broker Non-Votes 321,617,550 630,831 42,336 6,336,379”

APPIAN CORP shareholders approved Ratification of the selection of BDO USA, P.C. as independent registered public accounting firm for fiscal year 2026 at the 2026-06-03 meeting.

“Proposal 2 – Ratification of the Appointment of Independent Registered Public Accounting Firm The Company’s stockholders approved Proposal 2. The votes were cast as follows: Votes For Votes Against Abstained 328,493,007 64,169 69,920”

APPIAN CORP shareholders approved Election of eight nominees to serve as directors until the 2027 annual meeting at the 2026-06-03 meeting.

“Proposal 1 – Election of Directors The Company’s stockholders elected all nominees for director. The votes were cast as follows: Name Votes For Votes Withheld Broker Non-Votes Matthew Calkins 316,583,373 5,707,344 6,336,379 Michael Beckley 316,664,296 5,626,421 6,336,379 Robert C. Kramer 316,694,476 5,596,241 6,336,379 Shirley A. Edwards 315,706,899 6,583,818 6,336,379 Carl "Boe" Hartman II 321,883,825 406,892 6,336,379 Barbara "Bobbie" Kilberg 310,152,726 12,137,991 6,336,379 David Link 322,080,474 210,243 6,336,379 Mark Lynch 317,056,136 5,234,581 6,336,379”

INNODATA INC shareholders approved Approval of the Amended and Restated Innodata Inc. Equity Compensation Plan at the 2026-06-04 meeting.

“Proposal #4- Approval of the Amended and Restated Innodata Inc. Equity Compensation Plan: For Against Abstain Broker Non-Votes 10,164,046 370,278 87,875 8,877,299”

INNODATA INC shareholders approved Approval on a non-binding, advisory basis of the compensation of the Company’s named executive officers at the 2026-06-04 meeting.

“Proposal #3- Approval on a non-binding, advisory basis of the compensation of the Company’s named executive officers: For Against Abstain Broker Non-Votes 10,150,176 372,318 99,705 8,877,299”

INNODATA INC shareholders approved Ratification of the selection and appointment of BDO India Services Private Limited as the Company’s independent auditors for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.

“Proposal #2- Ratification of the selection and appointment of BDO India Services Private Limited as the Company’s independent auditors for the fiscal year ending December 31, 2026: For Against Abstain 19,006,381 364,937 128,180”

INNODATA INC shareholders approved Election of Directors at the 2026-06-04 meeting.

“Proposal #1- Election of Directors: Name For Withheld Broker Non-Votes Jack S. Abuhoff 10,402,786 219,413 8,877,299 Daniel H. (Don) Callahan 10,463,162 159,037 8,877,299 Richard D. Clarke 10,466,777 155,422 8,877,299 Louise C. Forlenza 10,056,562 565,637 8,877,299 Stewart R. Massey 9,620,745 1,001,454 8,877,299”

Prime Medicine, Inc. shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-05 meeting.

“On June 5, 2026, Prime Medicine, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”) in a virtual meeting format via live webcast. Proxies were solicited pursuant to the Company’s definitive proxy statement (the “Proxy Statement”) filed on April 23, 2026 with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended. As of the close of business on April 9, 2026, the record date for the Annual Meeting, the number of shares of the Company’s common stock, $0.00001 par value per share (“Common Stock”), outstanding and entitled to vote at the Annual Meeting was 180,615,889. The number of shares of Common Stock present in person or by remote communication, if applicable, or represented by valid proxy at the Annual Meeting was 140,384,724, thus establishing a quorum for the transaction of business at the Annual Meeting. Shares present virtually during the Annual Meeting were considered shares of Common St”

Prime Medicine, Inc. shareholders approved To elect Michael Kelly and David Schenkein, M.D. as Class I Directors. at the 2026-06-05 meeting.

“On June 5, 2026, Prime Medicine, Inc. (the “Company”) held its 2026 annual meeting of stockholders (the “Annual Meeting”) in a virtual meeting format via live webcast. Proxies were solicited pursuant to the Company’s definitive proxy statement (the “Proxy Statement”) filed on April 23, 2026 with the Securities and Exchange Commission under Section 14(a) of the Securities Exchange Act of 1934, as amended. As of the close of business on April 9, 2026, the record date for the Annual Meeting, the number of shares of the Company’s common stock, $0.00001 par value per share (“Common Stock”), outstanding and entitled to vote at the Annual Meeting was 180,615,889. The number of shares of Common Stock present in person or by remote communication, if applicable, or represented by valid proxy at the Annual Meeting was 140,384,724, thus establishing a quorum for the transaction of business at the Annual Meeting. Shares present virtually during the Annual Meeting were considered shares of Common St”

SI-BONE, Inc. shareholders approved Advisory vote to approve executive compensation.

“The compensation of the Company’s named executive officers as disclosed in the Proxy Statement was approved on an advisory basis. The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 33,265,992 2,579,849 17,463 3,041,727”

SI-BONE, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-12-31 meeting.

“The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified. The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 38,876,920 27,588 523 0”

SI-BONE, Inc. shareholders approved Election of Directors at the 2026-12-31 meeting.

“The following is a brief description of each matter voted upon at the Annual Meeting, as well as the final tally of the number of votes cast: (a) for or withheld with respect to the election of directors; (b) for or against, as well as abstentions, for the ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026; and (c) for or against, as well as abstentions, for the advisory vote to approve executive compensation.”

WillScot Holdings Corp shareholders approved Approval of the WillScot Holdings Corporation 2026 Incentive Award Plan.

“Proposal 5: Approval of the WillScot Holdings Corporation 2026 Incentive Award Plan The stockholders approved the 2026 Plan. The results of the vote taken are as follows: For Against Abstain Broker Non-Vote 164,794,091 1,689,226 77,991 6,676,367”

WillScot Holdings Corp shareholders approved Approval, by Advisory Vote, of the Frequency of Advisory Vote on the Compensation of the Company's Named Executive Officers.

“Proposal 4: Approval, by Advisory Vote, of the Frequency of Advisory Vote on the Compensation of the Company's Named Executive Officers The stockholders approved, on an advisory and non-binding basis, a one-year frequency of the future advisory votes on the compensation of the named executive officers. The results of the vote taken are as follows: 1 Year 2 Years 3 Years Abstain Broker Non-Vote 163,926,820 16,032 2,562,964 55,492 6,676,367”

WillScot Holdings Corp shareholders approved Approval, by Advisory Vote, of the Compensation of the Company's Named Executive Officers.

“Proposal 3: Approval, by Advisory Vote, of the Compensation of the Company’s Named Executive Officers The stockholders approved, on an advisory and non-binding basis, the compensation of the Company's named executive officers. The results of the vote taken are as follows: For Against Abstain Broker Non-Vote 162,254,222 4,185,472 121,614 6,676,367”

WillScot Holdings Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-12-31 meeting.

“Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the vote taken are as follows: For Against Abstain 172,744,598 427,067 66,010”

WillScot Holdings Corp shareholders approved Election of Directors.

“Proposal 1: Election of Directors The stockholders voted for all nine of management’s nominees for election as directors to serve for a term that will expire at the 2027 annual meeting of stockholders or until their successors are elected and qualified. The results of the vote taken are as follows: Nominee For Against Abstain Broker Non-Vote Timothy D. Boswell 166,304,397 151,018 105,893 6,676,367 Erika T. Davis 163,808,457 2,676,285 76,566 6,676,367 Gerard E. Holthaus 158,017,733 8,483,965 59,610 6,676,367 Worthing F. Jackman 165,331,473 1,181,795 48,040 6,676,367 Natalia N. Johnson 165,817,765 672,354 71,189 6,676,367 Rebecca L. Owen 159,973,268 6,512,047 75,993 6,676,367 Jeff Sagansky 160,087,407 6,425,505 48,396 6,676,367 Michael W. Upchurch 163,103,459 3,393,971 63,878 6,676,367 Dominick Zarcone 166,291,633 210,549 59,126 6,676,367”

Climb Bio, Inc. shareholders approved Approval of the 2021 Plan Amendment.

“4. The stockholders of the Company approved the 2021 Plan Amendment. The results of the stockholders’ vote with respect to such matter were as follows: Votes For Votes Against Abstentions Broker Non- Votes 19,604,493 7,810,582 16,229 7,841,185”

Climb Bio, Inc. shareholders rejected Amendment to the Amended and Restated Certificate of Incorporation relating to the removal of directors for cause.

“3. The stockholders of the Company did not approve an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, relating to the removal of directors for “cause”. The results of the stockholders’ vote with respect to such matter were as follows: Votes For Votes Against Abstentions Broker Non- Votes 27,299,535 130,187 1,582 7,841,185”

Climb Bio, Inc. shareholders approved Ratification of the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026 at the 2026-12-31 meeting.

“2. The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The results of the stockholders’ vote with respect to such matter were as follows: Votes For Votes Against Abstentions 35,206,304 63,633 2,552”

Climb Bio, Inc. shareholders approved Election of Alexander (Bo) Cumbo and Douglas Williams, Ph.D. to the Board of Directors.

“1. The stockholders of the Company elected Alexander (Bo) Cumbo and Douglas Williams, Ph.D., to the Company’s Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified. The results of the stockholders’ vote with respect to such matter were as follows: Votes For Votes Withheld Broker Non- Votes Alexander (Bo) Cumbo 26,035,689 1,395,615 7,841,185 Douglas Williams, Ph.D. 24,505,866 2,924,838 7,841,185”

Science Applications International Corp shareholders approved Ratification of appointment of Ernst & Young LLP as independent registered public accounting firm at the 2026-06-03 meeting.

“5. The proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 29, 2027 was approved based upon the following votes:”

Science Applications International Corp shareholders approved Proposal to amend the 2023 Equity Incentive Plan to increase authorized shares at the 2026-06-03 meeting.

“4. The proposal to the Company's 2023 Equity Incentive Plan to increase the total number of authorized shares was approved based upon the following votes:”

Science Applications International Corp shareholders approved Non-binding advisory vote on frequency of future Say-on-Pay votes at the 2026-06-03 meeting.

“3. The proposal to approve, on a non-binding, advisory basis, the frequency of future Say-on-Pay votes was approved based upon the following votes: Number of Votes For Every Year For Every Two Years For Every Three Years Abstain Broker Non-Votes 30,699,040 96,853 1,452,140 84,756 3,675,073”

Science Applications International Corp shareholders approved Non-binding advisory vote to approve named executive officer compensation at the 2026-06-03 meeting.

“2. The proposal to approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company as disclosed in the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 22, 2026 (or a say-on-pay vote) was approved based upon the following votes:”

Science Applications International Corp shareholders approved Election of Directors at the 2026-06-03 meeting.

“Science Applications International Corporation (the “Company”) held its virtual Annual Meeting of Stockholders on June 3, 2026 (the “Annual Meeting”).”

D-Wave Quantum Inc. shareholders approved Ratification of appointment of Grant Thornton LLP as independent auditor at the 2026-06-04 meeting.

“The voting results with respect to the ratification of the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 were as follows: For Against Abstain Broker Non-Votes 198,587,721 2,310,399 1,578,540 N/A”

D-Wave Quantum Inc. shareholders approved Advisory vote on the frequency of future say-on-pay votes at the 2026-06-04 meeting.

“The voting results with respect to the Say-on-Frequency Vote were as follows: One Year Two Years Three Years Abstain Broker Non-Votes 93,701,442 571,286 818,787 1,035,268 106,349,877”

D-Wave Quantum Inc. shareholders approved Advisory vote on the compensation of named executive officers at the 2026-06-04 meeting.

“The voting results with respect to the Say-on-Pay Vote were as follows: For Against Abstain Broker Non-Votes 90,652,337 4,572,341 902,105 106,349,877”

D-Wave Quantum Inc. shareholders approved Election of Alan E. Baratz and Sharon Holt as Class I directors at the 2026-06-04 meeting.

“The voting results with respect to the election of directors were as follows: For Withhold Broker Non-Votes Alan E. Baratz 94,418,236 1,708,547 106,349,877 Sharon Holt 82,745,067 13,381,716 106,349,877”

Jefferson Capital, Inc. / DE shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026 at the 2026-06-05 meeting.

“Item 2 - Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 58,327,463 52,556 423 0”

Jefferson Capital, Inc. / DE shareholders approved Election of three Class I director nominees to the Board for a term expiring at the 2029 annual meeting at the 2026-06-05 meeting.

“Item 1 - Election of three Class I director nominees to the Board for a term of office expiring on the date of the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes David Burton 47,404,927 9,408,046 1,567,469 Thomas Harding 46,566,739 10,246,234 1,567,469 Thomas Lydon, Jr. 46,727,742 10,085,231 1,567,469”

SEMTECH CORP shareholders approved Proposal Number 4 Amendment and Restatement of the Semtech Corporation 2017 Long-Term Equity Incentive Plan at the 2026-06-04 meeting.

“Proposal Number 4 Amendment and Restatement of the Semtech Corporation 2017 Long-Term Equity Incentive Plan Votes For Votes Against Votes Abstained Broker Non-Votes 79,476,950 1,603,864 108,075 4,082,627”

SEMTECH CORP shareholders approved Proposal Number 3 Advisory (Non-Binding) Vote on Executive Compensation at the 2026-06-04 meeting.

“Proposal Number 3 Advisory (Non-Binding) Vote on Executive Compensation Votes For Votes Against Votes Abstained Broker Non-Votes 79,073,683 1,919,240 195,966 4,082,627”

SEMTECH CORP shareholders approved Proposal Number 2 Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-04 meeting.

“Proposal Number 2 Ratification of Appointment of Independent Registered Public Accounting Firm Votes For Votes Against Votes Abstained Broker Non-Votes 84,825,309 346,449 99,758 0”

SEMTECH CORP shareholders approved Proposal Number 1 Election of Directors at the 2026-06-04 meeting.

“Proposal Number 1 Election of Directors Name Votes For Votes Withheld Broker Non-Votes Martin S.J. Burvill 80,447,436 741,453 4,082,627 Rodolpho C. Cardenuto 80,777,381 411,508 4,082,627 Gregory M. Fischer 80,824,293 364,596 4,082,627 Saar Gillai 80,659,648 529,241 4,082,627 Hong Q. Hou 80,945,844 243,045 4,082,627 Ye Jane Li 80,237,575 951,314 4,082,627 Paula LuPriore 80,853,787 335,102 4,082,627 Julie G. Ruehl 80,931,696 257,193 4,082,627 Paul V. Walsh, Jr. 80,813,594 375,295 4,082,627”

VINCE HOLDING CORP. shareholders approved Approval of the Plan Amendment and Restatement to increase by 1,000,000 the maximum aggregate number of shares of the Company's common stock issuable thereunder at the 2026-06-04 meeting.

“Proposal No. 4 – Approval of the Plan Amendment and Restatement to increase by 1,000,000 the maximum aggregate number of shares of the Company's common stock issuable thereunder. For Against Abstain Broker Non-Vote 7,582,358 420,949 178 2,298,423”

VINCE HOLDING CORP. shareholders approved Non-binding advisory vote on the compensation of the Company's named executive officers at the 2026-06-04 meeting.

“Proposal No. 3 – Approval of, on a non-binding, advisory basis, the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Vote 7,921,980 81,300 205 2,298,423”

VINCE HOLDING CORP. shareholders approved Ratification of appointment of PricewaterhouseCoopers, LLP as the Company's independent registered public accounting firm for the fiscal year ending January 30, 2027 at the 2026-06-04 meeting.

“Proposal No. 2 – Ratification of appointment of PricewaterhouseCoopers, LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 30, 2027. For Against Abstain 10,330,230 1,150 528”

VINCE HOLDING CORP. shareholders approved Election of one Class III director to serve until 2029 at the 2026-06-04 meeting.

“Proposal No. 1 – To elect one Class III director to serve until the Company’s annual meeting of stockholders to be held in 2029 or until his successor is duly elected and qualified. Nominee For Withheld Broker-Non-Vote Michael Mardy 7,459,977 543,508 2,298,423”

Beam Therapeutics Inc. shareholders approved Advisory vote on compensation of named executive officers at the 2026-06-03 meeting.

“Proposal 3 – The compensation of the Company’s named executive officers was approved, on an advisory basis, based on the following votes: For Against Abstentions Broker Non-Votes 71,546,749 985,066 273,533 13,419,659”

Beam Therapeutics Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-03 meeting.

“Proposal 2 – The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 was ratified, based on the following votes: For Against Abstentions 85,754,272 165,746 304,989”

Beam Therapeutics Inc. shareholders approved Election of three Class III directors at the 2026-06-03 meeting.

“Proposal 1 – The following nominees were elected as Class III directors to serve on the Company’s board of directors until the Company’s 2029 annual meeting of stockholders, and until his or her successor has been duly elected and qualified, based on the following votes: Nominee For Against Abstentions Broker Non-Votes John Evans 71,684,417 864,042 256,889 13,419,659 John Maraganore, Ph.D. 64,846,080 7,701,591 257,677 13,419,659 Christi Shaw 65,652,959 6,893,102 259,287 13,419,659”

Dyne Therapeutics, Inc. shareholders approved Ratification of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-05 meeting.

“The stockholders of the Company ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Dyne Therapeutics, Inc. shareholders approved Approval of amendment to restated certificate of incorporation to provide for officer exculpation at the 2026-06-05 meeting.

“The stockholders of the Company approved an amendment to the Company’s restated certificate of incorporation to provide for officer exculpation (the “Officer Exculpation Amendment”).”